about
Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.Divergent effects of platelet-endothelial cell adhesion molecule-1 and beta 3 integrin blockade on leukocyte transmigration in vivoEffect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery.Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venulesEpidemiological study of Guillain-Barré syndrome in south east EnglandInterferon gamma release assays and the NICE 2011 guidelines on the diagnosis of latent tuberculosis.The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy.National Healthcare Delivery Systems Influence Lung Transplant Outcomes for Cystic Fibrosis.The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial.Does donor catecholamine administration affect early lung function after transplantation?Early donor management increases the retrieval rate of lungs for transplantation.Donor cardiac troponin-I: a biochemical surrogate of heart function.Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.Measurement of extravascular lung water following human brain death: implications for lung donor assessment and transplantation.Left recurrent nerve paralysis associated with complete lung collapse with consolidation in an adult with cystic fibrosisPlatelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membraneAn anti-inflammatory property of aprotinin detected at the level of leukocyte extravasationCardiac herniation and lung torsion following heart and lung transplantation
P50
Q27309696-19F7C511-FCEB-4E12-81FD-DCE5105C64FAQ28582371-5FADFF30-53B5-46CC-9365-FA0CDADB76B0Q34141017-81488E25-C1B7-4F4C-914A-A026A7F8D0B4Q35044815-192982BF-CA91-46D5-8458-6F832D092071Q36317618-B222CAB8-0266-4976-A6D7-C9F8D52732FAQ42279621-E7EFB22B-FD65-4D2A-8DC4-ABADBEC4FE3DQ43288497-A17377AE-F5E1-4AD6-902C-ED5425721F75Q45075955-1C0B4865-2897-4A5B-A6B4-F56385CA4138Q46072906-AE3F4194-BD3E-4E1E-BBD4-FE41C8856D17Q46695745-B75CBC5C-5711-4D7B-BDB5-BF5CFC296501Q46836526-BBF1B80E-C84D-4F34-AD82-A8E210346A7BQ47940299-B8DBB6E0-FF1D-421C-805F-F69F50551D27Q47992020-0A69A2A5-A727-492C-9DAD-F2EBA9A51D61Q48231378-B2C6622A-C6A1-479E-8FF2-519EBB864E1AQ71947628-28338B34-1B2B-425C-92D1-D9BE8CF57A4AQ73586091-5876EC61-4F3B-4584-A00A-8A9ADBD84C5AQ74080733-20217865-5A53-4BD9-8712-90BB1B3DADC3Q83964997-D0DDEF00-B5BF-4855-8831-722FF55FDA8B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Richard D Thompson
@ast
Richard D Thompson
@en
Richard D Thompson
@es
Richard D Thompson
@nl
Richard D Thompson
@sl
type
label
Richard D Thompson
@ast
Richard D Thompson
@en
Richard D Thompson
@es
Richard D Thompson
@nl
Richard D Thompson
@sl
altLabel
Richard Thompson
@en
prefLabel
Richard D Thompson
@ast
Richard D Thompson
@en
Richard D Thompson
@es
Richard D Thompson
@nl
Richard D Thompson
@sl
P106
P21
P31
P496
0000-0003-1523-0944